Next Article in Journal
Trypanosome Infections and Anemia in Cattle Returning from Transhumance in Tsetse-Infested Areas of Cameroon
Next Article in Special Issue
Successive Acanthamoeba Corneal Isolates Identified in Poland Monitored in Terms of In Vitro Dynamics
Previous Article in Journal
Synergistic Antibacterial Activity of Benzalkonium Bromide and Cu-Bearing Duplex Stainless Steel against Pseudomonas aeruginosa
Previous Article in Special Issue
SLAMF7/STAT6 Pathway Inhibits Innate Immune Response in Late-Stage Human Acanthamoeba Keratitis: A Comparative Transcriptome Analysis
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Microorganisms
Volume 11
Issue 3
10.3390/microorganisms11030708
microorganisms-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles thumb_up
...
Endorse textsms
...
Comment
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Acanthamoeba castellanii Genotype T4: Inhibition of Proteases Activity and Cytopathic Effect by Bovine Apo-Lactoferrin

by
Gerardo Ramírez-Rico
1,2,†,
Moises Martinez-Castillo
3,4,†,
Roberto Cárdenas-Zúñiga
3,
Daniel Coronado-Velázquez
5,
Angélica Silva-Olivares
5,
Mireya De la Garza
1,
Mineko Shibayama
5,‡ and
Jesús Serrano-Luna
1,*
1
Department of Cell Biology, Center for Research and Advanced Studies, Mexico City 07360, Mexico
2
Faculty of Professional Studies, Autonomous National University of Mexico, Cuautitlan 54714, Mexico
3
Department of Experimental Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, TX 77054, USA
4
Liver, Pancreas and Motility Laboratory, Unit of Research in Experimental Medicine, School of Medicine, Autonomous National University of Mexico, General Hospital of Mexico, Mexico City 06726, Mexico
5
Department of Infectomics and Molecular Pathogenesis, Center for Research and Advanced Studies, Mexico City 07360, Mexico
*
Author to whom correspondence should be addressed.
†
These authors contributed equally to this work.
‡
This author has died.
Microorganisms 2023, 11(3), 708; https://doi.org/10.3390/microorganisms11030708
Submission received: 20 January 2023 / Revised: 6 March 2023 / Accepted: 7 March 2023 / Published: 9 March 2023
(This article belongs to the Special Issue Acanthamoeba spp. as Factors for Severe Infectious Diseases in Humans)
Browse Figures
Review Reports Versions Notes

Abstract

:
Acanthamoeba castellanii genotype T4 is a clinically significant free-living amoeba that causes granulomatous amoebic encephalitis and amoebic keratitis in human beings. During the initial stages of infection, trophozoites interact with various host immune responses, such as lactoferrin (Lf), in the corneal epithelium, nasal mucosa, and blood. Lf plays an important role in the elimination of pathogenic microorganisms, and evasion of the innate immune response is crucial in the colonization process. In this study, we describe the resistance of A. castellanii to the microbicidal effect of bovine apo-lactoferrin (apo-bLf) at different concentrations (25, 50, 100, and 500 µM). Acanthamoeba castellanii trophozoites incubated with apo-bLf at 500 µM for 12 h maintained 98% viability. Interestingly, despite this lack of effect on viability, our results showed that the apo-bLf inhibited the cytopathic effect of A. castellanii in MDCK cells culture, and analysis of amoebic proteases by zymography showed significant inhibition of cysteine and serine proteases by interaction with the apo-bLf. From these results, we conclude that bovine apo-Lf influences the activity of A. castellanii secretion proteases, which in turn decreases amoebic cytopathic activity.

1. Introduction

Free-living amoebae (FLA) are protozoa with a cosmopolitan distribution. This group of microorganisms can be isolated from soil, dust, air, drinking water, swimming pools, eyewash solutions, and contact lenses [1,2]. Acanthamoeba is a genus in the FLA group and is responsible for opportunistic and non-opportunistic infections in humans and other animals [2,3]. Acanthamoeba castellanii is a member of this genus, which promotes granulomatous amoebic encephalitis (GAE), cutaneous lesions, nasopharyngeal, and pulmonary infections in immunocompromised patients, whereas, in healthy people, it can cause amoebic keratitis (AK) [1]. During the infection process, these protozoa are in contact with immune factors, including the epithelial barrier, neutrophils, macrophages, mucus, immunoglobulins, and complement [4,5,6]. The mucus layer of mammals contains mucins, lysozyme, antimicrobial peptides, and lactoferrin (Lf), which are involved in the innate immune response [7]. Lf is an iron-binding glycoprotein that can exist in two functional forms: iron-associated (holo-Lf) and iron-free, apo-lactoferrin (apo-Lf). The latter is released by glandular epithelial cells and is found in the secondary granules of neutrophils [8,9]. The physiological concentration of this protein is in the range of 25 µM in mucosal secretions of the nose and eyes [10] and 80–90 µM in colostrum [11,12]. The increase in apo-Lf levels in tissues and the blood is usually associated with the inflammatory process induced by pathogens [8,13].
In 2012 it was demonstrated the protective effect of oral administration of Lf in the “dry eye syndrome” caused by an age-induced decrease in lacrimal gland secretory function [14]. It has also been well-documented that apo-Lf is able to protect the host in different ways during a microbial infection [15], including through bacteriostatic [16] and a bactericidal effects on Gram-negative and Gram-positive bacteria, causing permeability and damage in the outer membrane [17]. Additionally, Lf has been reported to have deleterious effects on the proliferation and colonization of a wide range of microorganisms, such as yeast, fungi, viruses, and protozoa [18,19,20,21,22,23]. Some studies on the interaction between FLA and apo-Lf have been reported; however, the microbicidal phenomenon was only partially evaluated, and the cellular mechanisms of apo-Lf activity on FLA are not completely understood [24]. Here, we studied the different microbiological effects of apo-Lf on A. castellanii. We found that A. castellanii possesses the ability to evade the amoebicidal and amoebostatic effects induced by bovine apo-Lf (apo-bLf). We also found that, despite this lack of effect, apo-bLf inhibits the cytopathic effect of A. castellanii on MDCK cells, possibly due to inhibition of the proteolytic activity of amoebic serine and cysteine proteases.

2. Materials and Methods

2.1. Culture of Acanthamoeba

Acanthamoeba castellanii genotype T4 (ATCC 50370) trophozoites were kindly provided by Dr. Simon Kilvington (Public Health Laboratory, Leicester, UK). These amoebae were obtained from human cases of Acanthamoeba Keratitis and were cultured at 25 °C in Chang’s medium supplemented with 10% (v/v) of fetal bovine serum (FBS; Equitech-bio, Kerrville, TX, USA). The identification and characterization were performed as previously described [25]. The A. castellanii were harvested during the logarithmic growth phase (48–72 h).

2.2. Viability Assays

To assess the viability of the amoebic cultures, trypan blue and FACs assays were performed. Briefly, 5 × 106 trophozoites were incubated with different concentrations (25, 50, 100, 300, and 500 µM) of apo-bLf (NutriScience Innovations, LLC, Milford, CT, USA) for 1, 3, 6, and 12 h. The apo-bLf was diluted in the respective amoebic culture medium without FBS. Apo-bLf-free and serum-free cultures of A. castellanii were used as the experimental controls.
For the trypan blue technique, trophozoites were recovered after each apo-bLf treatment. The amoebae were then incubated with 0.5% trypan blue, and at least 100 cells from five different fields were analyzed by light microscopy (Primostar, Carl Zeiss, Madrid, Spain). The results are reported as the percentage of live amoebae. In addition, a quantitative analysis of viability was performed using a fluorescent SYTOX Green assay (Invitrogen, Waltham, MA, USA) according to the supplier’s protocol. Serum-free cultures and trophozoites fixed with 2% paraformaldehyde (Sigma Aldrich, St. Louis, MO, USA) were used as experimental controls. The data were obtained using a FACS Calibur flow cytometer (Becton Dickinson, San Jose, CA, USA) and analyzed using Summit 5.1 software (Becton Dickinson, San Jose, CA, USA). Three independent assays were performed for both viability assays. The statistical analysis was performed by one-way ANOVA using GraphPad Prism 5.0 (p > 0.05) (GraphPad, San Diego, CA, USA).

2.3. Growth Curves

Acanthamoeba castellanii cell division during the interaction with apo-bLf was also evaluated. Briefly, 5 × 106 trophozoites were seeded in 15 mL sterile tubes (Corning, New York, NY, USA) and incubated with apo-bLf at the concentrations previously mentioned for 1, 3, 6, or 12 h. At each time interval, trophozoites were removed from the culture tube surface by chilling for 30 min. To determine the number of trophozoites, the samples were directly counted by light microscopy using a Bright-Line Hemacytometer (American Optical, Vernon Hills, IL, USA). As a control, the trophozoites were incubated in a serum-free medium. The statistical analysis of the three independent assays was performed by one-way ANOVA (p > 0.05) using GraphPad Prism 5.0 (GraphPad, CA, USA).

2.4. Transmission Electron Microscopy

For the ultrastructural analysis, the trophozoites were processed for transmission electron microscopy (TEM). The trophozoites were incubated with 500 µM of apo-bLf and fixed with 2.5% glutaraldehyde in 0.1 M of sodium cacodylate buffer (pH 7.2). Next, the samples were embedded in epoxy resin, and semi-thin sections were stained with toluidine blue (0.5%). The thin sections were contrasted with uranyl acetate and lead citrate and examined using an EM-910 Zeiss transmission electron microscope.

2.5. Cytopathic Effect of A. castellanii

The cytopathic effect on A. castellanii of different concentrations of apo-bLf was analyzed. Madin-Darby canine kidney (MDCK) cells were cultured in minimal essential medium (MEM) (Gibco, Grand Island, NY, USA) supplemented with 10% FBS in an atmosphere of 5% CO2 and at 37 °C for 48 h until they reached 95% confluence (monolayer). Subsequently, the trophozoites (1 × 106) were co-cultured with MDCK cells in serum-free MEM at 37 °C in a 1:1 ratio in 24-well culture plates (Corning, Glendale, CA, USA) in the presence of 500-µM apo-bLf. After 12 h, the trophozoites were removed by chilling for 30 min, and the integrity of the cell monolayers was observed by light microscopy. The MDCK cells without trophozoites, the MDCK cells incubated with apo-bLf (500 µM), and the MDCK cells incubated with the trophozoites without apo-bLf were used as experimental controls. Three independent assays were performed under each condition.

2.6. Zymography Assays

The protease activity was determined by 10% SDS-PAGE co-polymerized with 0.1% porcine gelatin (Sigma Aldrich, St. Louis, MO, USA), bovine (NutriScience Innovations, LLC, CT, Milford, CT, USA), and human apo-lactoferrin (Sigma Aldrich, St Louis, MO, USA). Total crude extracts (TCEs) of trophozoites incubated with or without 50, 100, and 500 µM apo-bLf were obtained as previously described [26], with some modifications. Briefly, the trophozoites were removed from the culture flask surface by chilling in an ice bath for 30 min, centrifuged at 800× g for 10 min, and washed with PBS 1X (pH 7.2). Subsequently, the trophozoites were lysed in PBS 1X (pH 7.2) by six freeze–thaw cycles with hot water and liquid nitrogen. Conditioned medium (CM) was prepared according to a previously-described protocol [27]. Briefly, six million trophozoites were placed into culture flasks containing 3 mL of fresh serum-free Chang´s medium, then incubated at 37 °C for 12 h. The CM was removed and centrifuged at 1500× g for 10 min, and finally passed through a 0.22 µm Durapore membrane (Millipore, Bedford, MA, USA). Next, the samples were precipitated with absolute ethanol at a 3:1 ratio and stored at −20 °C for 2 h. The CM was centrifuged at 6000× g for 30 min. The protein concentrations of the TCEs and CM were quantified using the Bradford method [28]. Fourteen µg of protein were loaded onto a gel for SDS-PAGE, performed at 4 °C in an ice bath at 80 V for 3 h. The gels were then washed twice with 2.5% (v/v) Triton X-100 solution (Sigma Aldrich, St Louis, MO, USA) for 30 min and incubated overnight with 100 mM of Tris-HCl (pH 7.0) and 2 mM of CaCl2. Finally, the gels were stained overnight with 0.5% (w/v) Coomassie Brilliant Blue R-250 (Bio-Rad, Feldkirchen, Germany). The protease activity was identified as clear bands on the blue background. Three independent assays were performed for each sample.

2.7. Protease Inhibitors

For the proteinase inhibition assays, the TCEs and CM were preincubated for 1 h at 37 °C with different protease inhibitors under constant agitation. The concentrations of inhibitors were as follows: for the cysteine proteases, 10 mM of p-hydroxymercuribenzoate (pHMB), and 10 µM of E-64; for the serine and cysteine proteases, 5 mM of phenylmethylsulfonyl fluoride (PMSF), and 1 mM of aprotinin (all the inhibitors were from Sigma Aldrich, St Louis, MO, USA). We loaded the samples onto 10% SDS-PAGE co-polymerized with 0.1% bovine apo-lactoferrin (NutriScience Innovations, LLC, Milford, CT, USA), and then performed electrophoresis at 4 °C in an ice bath at 80 V for 3 h. The gels were then washed twice with 2.5% (v/v) Triton X-100 solution (Sigma Aldrich, St Louis, MO, USA) for 30 min and incubated overnight with 100 mM of Tris-HCl (pH 7.0) and 2 mM of CaCl2. The gels were then stained overnight with 0.5% (w/v) Coomassie Brilliant Blue R-250 (Bio-Rad, Feldkirchen, Germany). Three independent assays were performed for each sample (26).

3. Results

3.1. Acanthamoeba castellanii Resists the Microbicidal Effect of apo-bLf

To evaluate the effect of apo-bLf on A. castellanii viability, the trophozoites were incubated with different concentrations of the apo-bLf for different time periods. The Trypan blue assay showed 95% viability at 1, 3, 6, and 12 h at 500 µM (high concentration) of apo-bLf, as compared to that of the untreated trophozoites (Figure 1). We also observed that after 6 h of incubation with 500 µM of apo-bLf, there was an increase in the size of the trophozoites, and they were slightly rounded.
Moreover, the cytometric analysis revealed that the A. castellanii trophozoites incubated with 500 µM of apo-bLf for 12 h maintained 98% viability (Figure 2c). These results were compared with those of the trophozoites cultured in the serum-free medium, which showed 97.2% viability (Figure 2a). As a positive control, the trophozoites were treated with paraformaldehyde for 1 h; the results showed about 7% trophozoite viability (Figure 2b). In both assays, we observed similar results; therefore, at physiological or even higher doses of apo-bLf (500 µM), there was no amoebicidal effect on the A. castellanii trophozoites.

3.2. Apo-bLf Does Not Have an Amoebostatic Effect on A. castellanii

It has been reported that apo-bLf induces amoebostatic effects; we therefore also evaluated the effect of apo-bLf on amoebic proliferation. A. castellanii trophozoites were incubated with different concentrations of apo-bLf, and the cultures were evaluated at 1, 3, 6, and 12 h. The counted cells revealed that the apo-bLf did not diminish the trophozoite growth rate, even at 500 µM apo-bLf (Figure 3). The growth rate at all time intervals was comparable to that in the serum-free medium (Figure 3); the differences were not statistically significant under any condition.

3.3. Ultrastructural Analysis of Trophozoites Treated with apo-bLf

To see whether there were morphological changes in amoebae treated with apo-bLf, we performed an ultrastructural analysis of A. castellanii trophozoites incubated with 500 µM of apo-bLf at the maximum time of study (12 h). The TEM analysis did not show any effect of the apo-bLf on the trophozoites. In the case of the apo-bLf-treated and non-treated A. castellanii, the amoebae showed typical morphological features of contractile vacuoles and nuclei (N) with a prominent nucleolus. The cytoplasmic membrane showed complete integrity, but with the presence of electron-dense material and an increase in the number and size of mitochondria (Figure 4).

3.4. Apo-bLf Inhibits the Cytopathic Effect of A. castellanii

To explore whether apo-bLf modifies the pathogenic capacity of A. castellanii, we performed in vitro assays using an epithelial cell line. The results showed that serum-free MDCK cells presented a normal morphology after 12 h, and similar results were observed in MDCK cells incubated only with apo-bLf (500 µM) (Figure 5a,b, respectively). In contrast, damage to the MDCK monolayer was evident in the presence of A. castellanii (Figure 5c). Interestingly, the cytopathic effect on the MDCK monolayers was reduced by the apo-bLf in co-cultures with A. castellanii after 12 h of incubation (Figure 5d).

3.5. Cysteine and Serine Proteases of A. castellanii Degrade Human and Bovine apo-Lactoferrin

To evaluate whether A. castellanii produces specific proteases with activity against apo-Lf, we performed zymography using human and bovine apo-Lf as substrates. Moreover, to evaluate the type of proteases involved in apo-bLf degradation, we used specific (E-64 and pHMB), partial (PMSF), and non-specific (aprotinin) inhibitors of cysteine proteases. The pHMB inhibitor completely decreased the proteases detected in TCEs (Figure 6a, lane 2), while the PMSF and E-64 slightly decreased the proteolytic profiles (Figure 6a, lanes 3 and 4). Additionally, the pHMB and PMSF inhibitors caused a reduction in the proteolytic patterns of the CM (Figure 6b, lanes 2 and 4). In addition, the results showed that the E-64 and aprotinin did not decrease the activity of the CM proteases (Figure 6b, lanes 3 and 5) compared to the CM not treated with the protease inhibitors. Similar results were obtained when we performed zymograms with apo-hLf, and two bands of proteolytic activity were found at 100 kDa and 55 kDa in the TCEs and CM, respectively (Supplementary Figure S1).

3.6. Apo-bLf Inhibits the Proteolytic Profile of A. castellanii

Acanthamoeba castellanii trophozoites produce and release a broad spectrum of proteases that are involved in different cellular and pathogenic mechanisms. Therefore, we decided to evaluate the effect of apo-bLf on amoebic protease activity. We used 10% SDS-PAGE co-polymerized with 0.1% porcine gelatin as the substrate. When 50 µM of apo-bLf was incubated with A. castellanii trophozoites for 1 h, a decrease in the proteolytic activity of the TCEs was observed (Figure 7a,b, lanes 3–4); while, with 500 µM of apo-bLf, the activity almost disappeared, with only a 150 kDa protease at the evaluated times (Figure 7a,b, lane 4) compared with the serum-free trophozoites without apo-bLf (Figure 7a,b, lane 1). In contrast, when we analyzed the CM, the A. castellanii showed that the proteolytic pattern was completely inhibited in the presence of apo-bLf at 12 h (Figure 7c,d, lanes 2–4) compared to the CM obtained from the trophozoites incubated with the serum-free medium without apo-bLf (Figure 7c,d, lane 1). All the gels were activated at 37 °C and pH 7.0.
Interestingly, in the assays zymography co-polymerized with 0.1% apo-bLf, the TCEs of A. castellanii that were not incubated with apo-bLf showed bands of proteolytic activity at 130 and 87.5 kDa, (Figure 8a,b, lane 1). In contrast, pre-incubation of the trophozoites with different concentrations of apo-bLf showed that the 130 kDa activity was maintained, but the 87.5 kDa activity was inhibited after 6 h (Figure 8a,b, lanes 2–4). Moreover, after 12 h of incubation, no proteolytic activity was observed (Figure 8b). When we analyzed the CM from the A. castellanii, we found two proteolytic activities of 130 and 70 kDa (Figure 8c,d, lane 1); however, these activities were abolished after 1 h of incubation with apo-bLf (Figure 8c,d, lanes 2–4).

4. Discussion

In mucosal tissues, several immune proteins, such as mucins, macroglobulins, immunoglobulins, defensins, lysozyme, and lactoferrin, actively participate in the elimination of pathogens [7]. Apo-lactoferrin is a multifunctional protein that is released by the mucoepithelial cells and secondary granules of neutrophils [8]. It has been implicated in several physiological functions, such as regulation of iron levels, anti-inflammatory activity, regulation of cellular growth and differentiation, protection against cancer, and host defense against a broad range of microbial infections [15,29,30,31]. It is important to mention that the microbicidal effect of apo-Lf in several microorganisms is not well understood; however, it seems to be related to bacterial membrane binding, which could alter membrane permeability through the dispersion of lipopolysaccharides and lead to cell death [17,29,31,32]. In contrast, apo-bLf is known to have fungicidal and antiparasitic activities [24,29,33,34].
During an A. castellanii infection of the eyes, these microorganisms interact directly with the apo-Lf from tears [35]. The interaction of apo-Lf with A. castellanii has been previously evaluated, showing an amoebicidal effect at a dose of 10 µM [36]. Initially, we wanted to know whether physiological concentrations of apo-bLf were able to kill A. castellanii trophozoites; however, we found that this protozoan was resistant. Therefore, we tested higher concentrations of apo-bLf, up to 500 µM; at all concentrations, we found viability greater than 95% of the trophozoites. We tested whether these high concentrations of apo-bLf could affect metabolic functions, such as virulence, of A. castellanii. Differences from previous studies could be due to the number of trophozoites that the authors reported (2 × 106) compared with our study (5 × 106). Another important difference may be related to the isolation method or strain of A. castellanii employed in each study (we employed A. castellanii ATCC 50370), which means that, in terms of specific Acanthamoeba strains, the susceptibility or resistance to Lf needs to be explored. In this context, a study of the incubation of A. castellanii with 1.48 mg/mL (19.24 µM) of Lf found that it does not cause alteration in the adhesion of A. castellanii on the SV40-human cornea epithelial cell line; however, the authors did not report the death of trophozoites under this condition [35].
Another mechanism related to apo-bLf is the microbiostatic effect, which has been correlated with the ability of Lf to chelate iron and render it unavailable to microorganisms [9,16,20]. This microbicidal effect has been reported in bacteria, fungi (Candida species), and protozoans such as Toxoplasma gondii, Trypanosoma brucei, T. cruzi, Giardia lamblia and Babesia caballi [18,19,37]. Interestingly, in our study, the growth curves did not show a microbiostatic effect of apo-bLf in A. castellanii cultures, even at higher concentrations and after 12 h of incubation. However, in the cultures of A. castellanii incubated with apo-bLf after 6 h, we observed some morphological changes by light microscopy, such as the amoebae becoming larger and slightly rounded. Moreover, in the TEM study, a thickening of the plasma membrane and an accumulation of electron-dense material in the cytoplasm were observed. We also observed an increase in the number of mitochondria, with an increase in their size with respect to the amoebae that were not treated with apo-bLf, which could be explained by a possible interaction between the apo-bLf and the A. castellanii trophozoites at the membrane level. The binding of Lf to the surface of E. histolytica trophozoites has also been reported [38]. A similar analysis was performed for pathogenic Candida species, where cell wall changes induced by apo-bLf were observed, causing eventual cell death [33]. However, in A. castellanii trophozoites, the antimicrobial activity of apo-bLf was not observed at higher concentrations. Even though there is no apparent effect on amoebic viability at high concentrations of apo-bLf, interestingly, when exploring the cytopathic effect of these amoebae on MDCK cells, inhibition of cell monolayer destruction was observed. This protective effect is consistent with a study reported by Coronado-Velazquez et al., where MDCK cells were incubated with A. mauritaniensis cells that were previously preincubated with serine protease inhibitors, resulting in an abolition of the cytopathic effect and a reduction in the degradation of epithelial tight junction proteins, demonstrating that Acanthameoba proteases are an important virulence factor for this pathogen [25]. The cytopathic effect is due to the secretion of cysteine and serine proteases. [25,26,27]. This led us to study the protease pattern of A. castellanii in both TCEs and CM. Protease inhibition revealed that cysteine proteases present in TCEs from A. castellanii trophozoites were involved in apo-bLf degradation. The proteases present in CM without apo-bLf revealed that cysteine and serine proteases could degrade the apo-bLf and holo-bLf. We previously reported that the secretion of cysteine proteases from A. castellanii is capable of degrading holo-Lf [27]. We found proteases with molecular weights of 56.6, 100, and 120 kDa in the TCEs and 60.2 and 100 kDa in the CM. They may be the same proteases that degrade apo-Lf, because the proteolytic degradation profiles were similar between both states of Lf, as well as non-specific, because these proteases are also capable of degrading other iron-associated proteins [27]. The degradation of holo-bLf by cysteine proteases present in the TCE of E. histolytica correlated with our results, where cysteine activities at 250, 100, 40, and 22 kDa cleaved holo-bLf at pH 7.0 and pH 4.0 [38]. Lf could bind to the cell membrane and be later internalized by the endosomal route to be degraded by cysteine proteases and used as a source of amino acids or as iron by cells, and apo-bLf could change to holo-bLf, due to iron chelation from the medium, and perhaps use the same pathway as reported in E. histolytica [38].
However, when A. castellanii trophozoites were incubated with apo-bLf, the protease secretion was inhibited and no proteolytic degradation was observed. Similar results were observed in zymograms co-polymerized with apo-bLf. These results could be due to apo-bLf functioning as a protease inhibitor or somehow inhibiting their secretion. These results are similar to those found in other microorganisms, such as Actinobacillus pleuropneumoniae and Mannheimia haemolytica [9,39]. In the enteropathogenic bacteria Escherichia coli (EPEC), which causes disease in several species, it has been reported that Lf damages the type III secretion system, the main secretion system of virulence factors in this bacterium, blocking actin polymerization and the degradation of EspB [40]. In our study, less inhibition was observed at lower concentrations of apo-bLf. Furthermore, in the COVID-19 pathology, caused by the viral agent SARS-CoV-2, proteolytic inhibition by peptides derived from bLf has been reported [41]. However, it is necessary to perform other assays, such as molecular docking, between proteases isolated from A. castellanii and apo-bLf and peptides derived from bLf (lactoferricin, lactoferrampin, and lactofungin).

5. Conclusions

Our results demonstrated that A. castellanii is one of the few microorganisms that can resist the amoebecidal or amoebestatic effects of apo-bLf. However, the apo-bLf inhibited the protease activity of A. castellanii and drastically reduced the cytopathic effects of the trophozoites on MDCK cells. Therefore, we believe that amoebic proteases are a key virulence factor during pathogenesis, and apo-bLf could be considered as a possible therapeutic alternative against A. castellanii.

Supplementary Materials

The following supporting information can be downloaded at: https://www.mdpi.com/article/10.3390/microorganisms11030708/s1, Figure S1: Inhibition of human apo-Lf proteases from TCE and CM from A. castellanii.

Author Contributions

Conceptualization, M.S., J.S.-L. and M.D.l.G.; methodology, G.R.-R., M.M.-C., R.C.-Z., D.C.-V. and A.S.-O.; formal analysis, G.R.-R., M.M.-C., R.C.-Z. and D.C.-V.; investigation, M.S., J.S.-L., M.D.l.G., G.R.-R., M.M.-C., R.C.-Z. and D.C.-V.; resources, M.S.; writing—original draft preparation, J.S.-L., G.R.-R. and M.M.-C. writing—review and editing, J.S.-L., G.R.-R. and M.M.-C. visualization, J.S.-L., G.R.-R. and M.M.-C.; supervision, M.S., J.S.-L. and M.D.l.G. project administration, M.S.; funding acquisition, M.S. All authors have read and agreed to the published version of the manuscript.

Funding

This research was funded by CONACyT, Grant 237523.

Data Availability Statement

Data sharing not applicable. No new data were created or analyzed in this study. Data sharing is not applicable to this article.

Acknowledgments

We are grateful to Diana Melissa Contreras-Zapata for her help with the zymography assays. In memory of Mineko Shibayama.

Conflicts of Interest

The authors declare no conflict of interest. The funders had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript; or in the decision to publish the results.

References

  1. Visvesvara, G.S. Infections with free-living amebae. Hand. Clin. Neurol. 2013, 114, 153–168. [Google Scholar] [CrossRef]
  2. Trabelsi, H.; Dendana, F.; Sellami, A.; Sellami, H.; Cheikhrouhou, F.; Neji, S.; Makni, F.; Ayadi, A. Pathogenic free-living amoebae: Epidemiology and clinical review. Pathol. Biol. 2012, 60, 399–405. [Google Scholar] [CrossRef]
  3. De Jonckheere, J.F. Origin and evolution of the worldwide distributed pathogenic amoeboflagellate Naegleria fowleri. Infect. Genet. Evol. 2011, 11, 1520–1528. [Google Scholar] [CrossRef]
  4. Rojas-Hernandez, S.; Jarillo-Luna, A.; Rodriguez-Monroy, M.; Moreno-Fierros, L.; Campos-Rodriguez, R. Immunohistochemical characterization of the initial stages of Naegleria fowleri meningoencephalitis in mice. Parasitol. Res. 2004, 94, 31–36. [Google Scholar] [CrossRef]
  5. Marciano-Cabral, F.; Cabral, G.A. The immune response to Naegleria fowleri amebae and pathogenesis of infection. FEMS Immunol. Med. Microbiol. 2007, 51, 243–259. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  6. Ferrante, A. Free-living amoebae: Pathogenicity and immunity. Parasite Immunol. 1991, 13, 31–47. [Google Scholar] [CrossRef] [PubMed]
  7. Quraishi, M.S.; Jones, N.S.; Mason, J. The rheology of nasal mucus: A review. Clin. Otolaryngol. Allied. Sci. 1998, 23, 403–413. [Google Scholar] [CrossRef] [PubMed]
  8. Ortiz-Estrada, G.; Luna-Castro, S.; Pina-Vazquez, C.; Samaniego-Barron, L.; Leon-Sicairos, N.; Serrano-Luna, J.; de la Garza, M. Iron-saturated lactoferrin and pathogenic protozoa: Could this protein be an iron source for their parasitic style of life? Future Microbiol. 2012, 7, 149–164. [Google Scholar] [CrossRef]
  9. Luna-Castro, S.; Aguilar-Romero, F.; Samaniego-Barron, L.; Godinez-Vargas, D.; de la Garza, M. Effect of bovine apo-lactoferrin on the growth and virulence of Actinobacillus pleuropneumoniae. Biometals Int. J. Role Met. Ions Biol. Biochem. Med. 2014, 27, 891–903. [Google Scholar] [CrossRef]
  10. Flanagan, J.L.; Willcox, M.D. Role of lactoferrin in the tear film. Biochimie 2009, 91, 35–43. [Google Scholar] [CrossRef]
  11. De la Rosa, G.; Yang, D.; Tewary, P.; Varadhachary, A.; Oppenheim, J.J. Lactoferrin acts as an alarmin to promote the recruitment and activation of APCs and antigen-specific immune responses. J. Immunol. 2008, 180, 6868–6876. [Google Scholar] [CrossRef] [Green Version]
  12. Levay, P.F.; Viljoen, M. Lactoferrin: A general review. Haematologica 1995, 80, 252–267. [Google Scholar]
  13. Avalos-Gomez, C.; Ramirez-Rico, G.; Ruiz-Mazon, L.; Sicairos, N.L.; Serrano-Luna, J.; de la Garza, M. Lactoferrin: An Effective Weapon in the Battle Against Bacterial Infections. Curr. Pharm. Des. 2022, 40, 3243–3260. [Google Scholar] [CrossRef]
  14. Kawashima, M.; Kawakita, T.; Inaba, T.; Okada, N.; Ito, M.; Shimmura, S.; Watanabe, M.; Shinmura, K.; Tsubota, K. Dietary lactoferrin alleviates age-related lacrimal gland dysfunction in mice. PLoS ONE 2012, 7, e33148. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  15. Ward, P.P.; Paz, E.; Conneely, O.M. Multifunctional roles of lactoferrin: A critical overview. Cell Mol. Life Sci. 2005, 62, 2540–2548. [Google Scholar] [CrossRef]
  16. Rainard, P. Bacteriostatic activity of bovine lactoferrin in mastitic milk. Vet. Microbiol. 1987, 13, 159–166. [Google Scholar] [CrossRef] [PubMed]
  17. Ellison, R.T., 3rd; Giehl, T.J.; LaForce, F.M. Damage of the outer membrane of enteric gram-negative bacteria by lactoferrin and transferrin. Infect. Immun. 1988, 56, 2774–2781. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  18. Dzitko, K.; Dziadek, B.; Dziadek, J.; Dlugonska, H. Toxoplasma gondii: Inhibition of the intracellular growth by human lactoferrin. Pol. J. Microbiol. 2007, 56, 25–32. [Google Scholar]
  19. Ikadai, H.; Tanaka, T.; Shibahara, N.; Tanaka, H.; Matsuu, A.; Kudo, N.; Shimazaki, K.; Igarashi, I.; Oyamada, T. Inhibitory effect of lactoferrin on in vitro growth of Babesia caballi. Am. J. Trop. Med. Hyg. 2005, 73, 710–712. [Google Scholar] [CrossRef]
  20. Leon-Sicairos, N.; Reyes-Lopez, M.; Ordaz-Pichardo, C.; de la Garza, M. Microbicidal action of lactoferrin and lactoferricin and their synergistic effect with metronidazole in Entamoeba histolytica. Biochem. Cell Biol. 2006, 84, 327–336. [Google Scholar] [CrossRef]
  21. Manzoni, P.; Stolfi, I.; Messner, H.; Cattani, S.; Laforgia, N.; Romeo, M.G.; Bollani, L.; Rinaldi, M.; Gallo, E.; Quercia, M.; et al. Bovine lactoferrin prevents invasive fungal infections in very low birth weight infants: A randomized controlled trial. Pediatrics 2012, 129, 116–123. [Google Scholar] [CrossRef]
  22. Ochoa, T.J.; Chea-Woo, E.; Campos, M.; Pecho, I.; Prada, A.; McMahon, R.J.; Cleary, T.G. Impact of lactoferrin supplementation on growth and prevalence of Giardia colonization in children. Clin. Infect. Dis. Off. Publ. Infect. Dis. Soc. Am. 2008, 46, 1881–1883. [Google Scholar] [CrossRef] [Green Version]
  23. Waarts, B.L.; Aneke, O.J.; Smit, J.M.; Kimata, K.; Bittman, R.; Meijer, D.K.; Wilschut, J. Antiviral activity of human lactoferrin: Inhibition of alphavirus interaction with heparan sulfate. Virology 2005, 333, 284–292. [Google Scholar] [CrossRef] [Green Version]
  24. Reyes-Lopez, M.; Ramirez-Rico, G.; Serrano-Luna, J.; de la Garza, M. Activity of Apo-Lactoferrin on Pathogenic Protozoa. Pharmaceutics 2022, 14, 1702. [Google Scholar] [CrossRef]
  25. Coronado-Velazquez, D.; Silva-Olivares, A.; Castro-Munozledo, F.; Lares-Jimenez, L.F.; Rodriguez-Anaya, L.Z.; Shibayama, M.; Serrano-Luna, J. Acanthamoeba mauritaniensis genotype T4D: An environmental isolate displays pathogenic behavior. Parasitol. Int. 2020, 74, 102002. [Google Scholar] [CrossRef]
  26. Serrano-Luna, J.; Cervantes-Sandoval, I.; Calderon, J.; Navarro-Garcia, F.; Tsutsumi, V.; Shibayama, M. Protease activities of Acanthamoeba polyphaga and Acanthamoeba castellanii. Can. J. Microbiol. 2006, 52, 16–23. [Google Scholar] [CrossRef]
  27. Ramirez Rico, G.; Martinez-Castillo, M.; de la Garza, M.; Shibayama, M.; Serrano-Luna, J. Acanthamoeba castellanii Proteases are Capable of Degrading Iron-Binding Proteins as a Possible Mechanism of Pathogenicity. J. Eukaryot. Microbiol. 2015, 62, 614–622. [Google Scholar] [CrossRef]
  28. Bradford, M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 1976, 72, 248–254. [Google Scholar] [CrossRef] [PubMed]
  29. Wiesner, J.; Vilcinskas, A. Antimicrobial peptides: The ancient arm of the human immune system. Virulence 2010, 1, 440–464. [Google Scholar] [CrossRef] [PubMed]
  30. Ramirez-Rico, G.; Drago-Serrano, M.E.; Leon-Sicairos, N.; de la Garza, M. Lactoferrin: A Nutraceutical with Activity against Colorectal Cancer. Front. Pharm. 2022, 13, 855852. [Google Scholar] [CrossRef] [PubMed]
  31. Zarzosa-Moreno, D.; Avalos-Gomez, C.; Ramirez-Texcalco, L.S.; Torres-Lopez, E.; Ramirez-Mondragon, R.; Hernandez-Ramirez, J.O.; Serrano-Luna, J.; de la Garza, M. Lactoferrin and Its Derived Peptides: An Alternative for Combating Virulence Mechanisms Developed by Pathogens. Molecules 2020, 25, 5763. [Google Scholar] [CrossRef]
  32. Aguila, A.; Herrera, A.G.; Morrison, D.; Cosgrove, B.; Perojo, A.; Montesinos, I.; Perez, J.; Sierra, G.; Gemmell, C.G.; Brock, J.H. Bacteriostatic activity of human lactoferrin against Staphylococcus aureus is a function of its iron-binding properties and is not influenced by antibiotic resistance. FEMS Immunol. Med. Microbiol. 2001, 31, 145–152. [Google Scholar] [CrossRef] [PubMed]
  33. Xu, Y.Y.; Samaranayake, Y.H.; Samaranayake, L.P.; Nikawa, H. In vitro susceptibility of Candida species to lactoferrin. Med. Mycol. 1999, 37, 35–41. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  34. Tanaka, T.; Omata, Y.; Saito, A.; Shimazaki, K.; Igarashi, I.; Suzuki, N. Growth inhibitory effects of bovine lactoferrin to Toxoplasma gondii parasites in murine somatic cells. J. Vet. Med. Sci. 1996, 58, 61–65. [Google Scholar] [CrossRef] [Green Version]
  35. Alsam, S.; Jeong, S.R.; Dudley, R.; Khan, N.A. Role of human tear fluid in Acanthamoeba interactions with the human corneal epithelial cells. Int. J. Med. Microbiol. 2008, 298, 329–336. [Google Scholar] [CrossRef] [PubMed]
  36. Tomita, S.; Suzuki, C.; Wada, H.; Nomachi, M.; Imayasu, M.; Araki-Sasaki, K. Effects of lactoferrin on the viability and the encystment of Acanthamoeba trophozoites. Biochem. Cell Biol. 2017, 95, 48–52. [Google Scholar] [CrossRef]
  37. Leboffe, L.; Giansanti, F.; Antonini, G. Antifungal and Antiparasitic Activities of Lactoferrin. Anti-Infect. Agents Med. Chem. 2009, 8, 114–127. [Google Scholar] [CrossRef]
  38. Leon-Sicairos, N.; Reyes-Lopez, M.; Canizalez-Roman, A.; Bermudez-Cruz, R.M.; Serrano-Luna, J.; Arroyo, R.; de la Garza, M. Human hololactoferrin: Endocytosis and use as an iron source by the parasite Entamoeba histolytica. Microbiology 2005, 151, 3859–3871. [Google Scholar] [CrossRef] [Green Version]
  39. Ramírez-Rico, G.; Martinez-Castillo, M.; Avalos-Gómez, C.; De la Garza, M. Bovine apo-lactoferrin affects the secretion of proteases in Mannheimia haemolytica A2. Acces Microbiol. 2021, 3, 269. [Google Scholar] [CrossRef]
  40. Ochoa, T.J.; Noguera-Obenza, M.; Ebel, F.; Guzman, C.A.; Gomez, H.F.; Cleary, T.G. Lactoferrin impairs type III secretory system function in enteropathogenic Escherichia coli. Infect. Immun. 2003, 71, 5149–5155. [Google Scholar] [CrossRef] [Green Version]
  41. Zhao, W.; Li, X.; Yu, Z.; Wu, S.; Ding, L.; Liu, J. Identification of lactoferrin-derived peptides as potential inhibitors against the main protease of SARS-CoV-2. Leb. Wiss Technol. 2022, 154, 112684. [Google Scholar] [CrossRef] [PubMed]
Microorganisms 11 00708 g001 550
Figure 1. Light microscopy with Trypan blue exclusion assay. Acanthamoeba castellanii trophozoites were incubated with 500 µM of apo-bLf at 1 (a,b), 3 (c,d), 6 (e,f), and 12 (g,h) hours of incubation. Dead trophozoites (blue) are seen throughout the displayed fields. The presence of some trophozoites with acanthopods (arrows) and cysts (arrowheads) stands out. Representative results of at least three trials, each with independent samples.
Figure 1. Light microscopy with Trypan blue exclusion assay. Acanthamoeba castellanii trophozoites were incubated with 500 µM of apo-bLf at 1 (a,b), 3 (c,d), 6 (e,f), and 12 (g,h) hours of incubation. Dead trophozoites (blue) are seen throughout the displayed fields. The presence of some trophozoites with acanthopods (arrows) and cysts (arrowheads) stands out. Representative results of at least three trials, each with independent samples.
Microorganisms 11 00708 g001
Microorganisms 11 00708 g002 550
Figure 2. Viability of A. castellanii trophozoites incubated with 500 µM of apo-bLf. (a) About 97.2% of the A. castellanii trophozoites showed a weak SYTOX fluorescent marker at 12 h in the serum-free medium. (b) Trophozoites treated with paraformaldehyde for 1 h showed that the viability of A. castellanii was reduced to 7%. Acanthamoeba castellanii co-incubated with 500 µM of apo-bLf showed 98% viable cells. (c) The dead trophozoites were labeled with SYTOX Green (15 nM) and evaluated in a FACSCalibur flow cytometer. The results were analyzed with Summit 5.1 software. At least 20,000 events were counted for each condition. The results are expressed as percent of viable cells. Three independent assays were performed (p > 0.05).
Figure 2. Viability of A. castellanii trophozoites incubated with 500 µM of apo-bLf. (a) About 97.2% of the A. castellanii trophozoites showed a weak SYTOX fluorescent marker at 12 h in the serum-free medium. (b) Trophozoites treated with paraformaldehyde for 1 h showed that the viability of A. castellanii was reduced to 7%. Acanthamoeba castellanii co-incubated with 500 µM of apo-bLf showed 98% viable cells. (c) The dead trophozoites were labeled with SYTOX Green (15 nM) and evaluated in a FACSCalibur flow cytometer. The results were analyzed with Summit 5.1 software. At least 20,000 events were counted for each condition. The results are expressed as percent of viable cells. Three independent assays were performed (p > 0.05).
Microorganisms 11 00708 g002
Microorganisms 11 00708 g003 550
Figure 3. Growth curves of A. castellanii trophozoites incubated with different apo-bLf concentrations. Cellular division of A. castellanii was maintained at all apo-bLf, concentrations tested (25, 50, 100, 300, and 500 µM). Trophozoites in the serum-free medium were used as the experimental control (Chang). Data analyses were performed with GraphPad Prism 5.0. All bars show the mean ± SEM of three independent assays (p > 0.05).
Figure 3. Growth curves of A. castellanii trophozoites incubated with different apo-bLf concentrations. Cellular division of A. castellanii was maintained at all apo-bLf, concentrations tested (25, 50, 100, 300, and 500 µM). Trophozoites in the serum-free medium were used as the experimental control (Chang). Data analyses were performed with GraphPad Prism 5.0. All bars show the mean ± SEM of three independent assays (p > 0.05).
Microorganisms 11 00708 g003
Microorganisms 11 00708 g004 550
Figure 4. Transmission electron microscopy of A. castellanii after apo-bLf incubation. (a) A. castellanii trophozoites were incubated in serum-free medium for 12 h. They present a normal nucleus (N) with prominent nucleolus, intact membrane, and multiple healthy mitochondria; (b) A. castellanii incubated with 500 µM of apo-bLf. Some trophozoites showed high density in the cytoplasmic membrane (arrows) and an increase in intracytoplasmic electron-dense material, and high density in the mitochondria (arrowheads). Both, A. castellanii untreated and treated with 500 µM of apo-bLf show integrity of organelles and cytoplasmic membrane. EM-910 Zeiss. Bars = 1 µm.
Figure 4. Transmission electron microscopy of A. castellanii after apo-bLf incubation. (a) A. castellanii trophozoites were incubated in serum-free medium for 12 h. They present a normal nucleus (N) with prominent nucleolus, intact membrane, and multiple healthy mitochondria; (b) A. castellanii incubated with 500 µM of apo-bLf. Some trophozoites showed high density in the cytoplasmic membrane (arrows) and an increase in intracytoplasmic electron-dense material, and high density in the mitochondria (arrowheads). Both, A. castellanii untreated and treated with 500 µM of apo-bLf show integrity of organelles and cytoplasmic membrane. EM-910 Zeiss. Bars = 1 µm.
Microorganisms 11 00708 g004
Microorganisms 11 00708 g005 550
Figure 5. Inhibition of cytopathic effect by apo-bLf in A. castellanii. (a) MDCK monolayer with serum-free medium and (b) with apo-bLf (500 µM) showed a continuous typical monolayer morphology at 12 h of culture. (c) Alteration of MDCK cells by A. castellanii at 12 h. (d) Inhibition of cytopathic effect of A. castellanii by apo-bLf at 12 h of co-incubation.
Figure 5. Inhibition of cytopathic effect by apo-bLf in A. castellanii. (a) MDCK monolayer with serum-free medium and (b) with apo-bLf (500 µM) showed a continuous typical monolayer morphology at 12 h of culture. (c) Alteration of MDCK cells by A. castellanii at 12 h. (d) Inhibition of cytopathic effect of A. castellanii by apo-bLf at 12 h of co-incubation.
Microorganisms 11 00708 g005
Microorganisms 11 00708 g006 550
Figure 6. Inhibition of apo-bLf proteases from TCE and CM from A. castellanii. Zymography using 10% SDS-PAGE co-polymerized with 0.1% apo-bLf. Samples of TCE (a) and CM (b) from A. castellanii trophozoites were incubated for 1 h with different protease inhibitors: pHMB (lane 2), E-64 (lane 3), PMSF (lane 4), and aprotinin (lane 5). Untreated A. castellanii trophozoites without inhibitors were used as the experimental control ((a,b) lanes 1). The gels were activated overnight at 37 °C and pH 7.0. Three independent assays were performed.
Figure 6. Inhibition of apo-bLf proteases from TCE and CM from A. castellanii. Zymography using 10% SDS-PAGE co-polymerized with 0.1% apo-bLf. Samples of TCE (a) and CM (b) from A. castellanii trophozoites were incubated for 1 h with different protease inhibitors: pHMB (lane 2), E-64 (lane 3), PMSF (lane 4), and aprotinin (lane 5). Untreated A. castellanii trophozoites without inhibitors were used as the experimental control ((a,b) lanes 1). The gels were activated overnight at 37 °C and pH 7.0. Three independent assays were performed.
Microorganisms 11 00708 g006
Microorganisms 11 00708 g007 550
Figure 7. Proteolytic patterns from A. castellanii after apo-bLf incubation. Zymography using 10% SDS-PAGE co-polymerized with 0.1% porcine gelatin. Proteases of TCEs ((a,b) lane 1) and CM ((c,d) lane 1) from A. castellanii without incubation with apo-bLf. TCEs (a,b) and CM (c,d) from A. castellanii obtained after 1 h (a,c), and 12 h (b,d) of co-incubation with different concentrations of apo-bLf: 50 µM (Lane 2), 100 µM (lane 3), and 500 µM (lane 4). Three independent assays were performed.
Figure 7. Proteolytic patterns from A. castellanii after apo-bLf incubation. Zymography using 10% SDS-PAGE co-polymerized with 0.1% porcine gelatin. Proteases of TCEs ((a,b) lane 1) and CM ((c,d) lane 1) from A. castellanii without incubation with apo-bLf. TCEs (a,b) and CM (c,d) from A. castellanii obtained after 1 h (a,c), and 12 h (b,d) of co-incubation with different concentrations of apo-bLf: 50 µM (Lane 2), 100 µM (lane 3), and 500 µM (lane 4). Three independent assays were performed.
Microorganisms 11 00708 g007
Microorganisms 11 00708 g008 550
Figure 8. Proteases of TCEs and CM in zymograms using 10% SDS-PAGE co-polymerized with 0.1% bovine apo-lactoferrin. Untreated (lane 1) and treated-bLf (2–4) TCEs (a,b) and CM (c,d) from A. castellanii showed apo-bLf degradation. TCEs and CM from A. castellanii obtained at 1 h (a,c) and 12 h (b,d) of co-incubation with different concentrations of apo-bLf: 50 µM (lane 2), 100 µM (lane 3), and 500 µM (lane 4). All gels were activated at pH 7.0 and 37 °C. Three zymography assays with independent samples were performed.
Figure 8. Proteases of TCEs and CM in zymograms using 10% SDS-PAGE co-polymerized with 0.1% bovine apo-lactoferrin. Untreated (lane 1) and treated-bLf (2–4) TCEs (a,b) and CM (c,d) from A. castellanii showed apo-bLf degradation. TCEs and CM from A. castellanii obtained at 1 h (a,c) and 12 h (b,d) of co-incubation with different concentrations of apo-bLf: 50 µM (lane 2), 100 µM (lane 3), and 500 µM (lane 4). All gels were activated at pH 7.0 and 37 °C. Three zymography assays with independent samples were performed.
Microorganisms 11 00708 g008
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Ramírez-Rico, G.; Martinez-Castillo, M.; Cárdenas-Zúñiga, R.; Coronado-Velázquez, D.; Silva-Olivares, A.; De la Garza, M.; Shibayama, M.; Serrano-Luna, J. Acanthamoeba castellanii Genotype T4: Inhibition of Proteases Activity and Cytopathic Effect by Bovine Apo-Lactoferrin. Microorganisms 2023, 11, 708. https://doi.org/10.3390/microorganisms11030708

AMA Style

Ramírez-Rico G, Martinez-Castillo M, Cárdenas-Zúñiga R, Coronado-Velázquez D, Silva-Olivares A, De la Garza M, Shibayama M, Serrano-Luna J. Acanthamoeba castellanii Genotype T4: Inhibition of Proteases Activity and Cytopathic Effect by Bovine Apo-Lactoferrin. Microorganisms. 2023; 11(3):708. https://doi.org/10.3390/microorganisms11030708

Chicago/Turabian Style

Ramírez-Rico, Gerardo, Moises Martinez-Castillo, Roberto Cárdenas-Zúñiga, Daniel Coronado-Velázquez, Angélica Silva-Olivares, Mireya De la Garza, Mineko Shibayama, and Jesús Serrano-Luna. 2023. "Acanthamoeba castellanii Genotype T4: Inhibition of Proteases Activity and Cytopathic Effect by Bovine Apo-Lactoferrin" Microorganisms 11, no. 3: 708. https://doi.org/10.3390/microorganisms11030708

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop